Literature DB >> 18761964

Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006.

F Dubois-Arber1, H Balthasar, T Huissoud, F Zobel, S Arnaud, S Samitca, A Jeannin, D Schnoz, J P Gervasoni.   

Abstract

As a part of the HIV behavioural surveillance system in Switzerland, repeated cross-sectional surveys were conducted in 1993, 1994, 1996, 2000 and 2006 among attenders of all low threshold facilities (LTFs) with needle exchange programmes and/or supervised drug consumption rooms for injection or inhalation in Switzerland. Data were collected in each LTF over five consecutive days, using a questionnaire that was partly completed by an interviewer and partly self administered. The questionnaire was structured around three topics: socio-demographic characteristics, drug consumption, health and risk/preventive behaviour. Analysis was restricted to attenders who had injected drugs during their lifetime (IDUs). Between 1993 and 2006, the median age of IDUs rose by 10 years. IDUs are severely marginalised and their social situation has improved little. The borrowing of used injection equipment (syringe or needle already used by other person) in the last six months decreased (16.5% in 1993, 8.9% in 2006) but stayed stable at around 10% over the past three surveys. Other risk behaviour, such as sharing spoons, cotton or water, was reported more frequently, although also showed a decreasing trend. The reported prevalence of HIV remained fairly stable at around 10% between 1993 and 2006; reported levels of hepatitis C virus (HCV) prevalence were high (56.4% in 2006). In conclusion, the overall decrease in the practice of injection has reduced the potential for transmission of infections. However as HCV prevalence is high this is of particular concern, as the current behaviour of IDUs indicates a potential for further spreading of the infection. Another noteworthy trend is the significant decrease in condom use in the case of paid sex.

Entities:  

Mesh:

Year:  2008        PMID: 18761964     DOI: 10.2807/ese.13.21.18881-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  9 in total

1.  Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs.

Authors:  Dan Werb
Journal:  Int J Drug Policy       Date:  2017-07-19

Review 2.  Injection Drug Use Trajectories among Migrant Populations: A Narrative Review.

Authors:  Jason S Melo; Maria Luisa Mittal; Danielle Horyniak; Steffanie A Strathdee; Dan Werb
Journal:  Subst Use Misuse       Date:  2018-01-24       Impact factor: 2.164

3.  The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  Int J Drug Policy       Date:  2011-07-20

Review 4.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

5.  Health problems among detainees in Switzerland: a study using the ICPC-2 classification.

Authors:  Hans Wolff; Paul Sebo; Dagmar M Haller; Ariel Eytan; Gérard Niveau; Dominique Bertrand; Laurent Gétaz; Bernard Cerutti
Journal:  BMC Public Health       Date:  2011-04-19       Impact factor: 3.295

6.  Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.

Authors:  Beat Müllhaupt; Philip Bruggmann; Florian Bihl; Sarah Blach; Daniel Lavanchy; Homie Razavi; David Semela; Francesco Negro
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

7.  Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.

Authors:  Michael Liebrenz; Rudolf Stohler; Carlos Nordt
Journal:  Harm Reduct J       Date:  2014-08-18

Review 8.  The North American opioid epidemic: current challenges and a call for treatment as prevention.

Authors:  Devesh Vashishtha; Maria Luisa Mittal; Daniel Werb
Journal:  Harm Reduct J       Date:  2017-05-12

9.  Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.

Authors:  Olivier Schorr; Sarah Blach; Christine Thurnheer; Christian Ruis; Jean-Francois Dufour
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.